Jan. 16, 2014
Star Scientific Inc. says it's working with the Food and Drug Administration to avoid having to pull two dietary supplement products from the market.
Dr. Michael Mullan, the company's new CEO, held a short conference call Wednesday to discuss recent developments with investors.
Media outlets report that Mullan acknowledged that Star Scientific could be required to discontinue marketing Anatabloc and CigRx as dietary supplements.
In December, the FDA sent a warning letter to the company saying that the products contain a new dietary ingredient that requires federal approval before it can be marketed. Star Scientific did not seek such approval.
The FDA also said Star Scientific's website improperly promotes Anatabloc as a drug by suggesting it can be used to treat various diseases.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.